X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (29) 29
humans (29) 29
oncology (27) 27
middle aged (26) 26
aged (22) 22
adult (17) 17
breast neoplasms - drug therapy (17) 17
chemotherapy (16) 16
antineoplastic combined chemotherapy protocols - therapeutic use (15) 15
antineoplastic combined chemotherapy protocols - adverse effects (11) 11
breast cancer (11) 11
disease-free survival (11) 11
breast neoplasms - pathology (10) 10
chemotherapy, adjuvant (10) 10
prospective studies (10) 10
survival (10) 10
survival rate (10) 10
treatment outcome (10) 10
breast neoplasms - mortality (9) 9
prognosis (9) 9
tamoxifen - therapeutic use (9) 9
therapy (9) 9
follow-up studies (8) 8
women (8) 8
antineoplastic agents, hormonal - therapeutic use (7) 7
breast neoplasms - surgery (7) 7
index medicus (7) 7
postmenopausal women (7) 7
tamoxifen (7) 7
adhesives (6) 6
aged, 80 and over (6) 6
chemical paint or ink removers (6) 6
chemistry (6) 6
coating compositions, e.g. paints, varnishes orlacquers (6) 6
correcting fluids (6) 6
drug administration schedule (6) 6
dyes (6) 6
filling pastes (6) 6
granulocyte colony-stimulating factor - administration & dosage (6) 6
inks (6) 6
lymphatic metastasis (6) 6
male (6) 6
metallurgy (6) 6
miscellaneous applications of materials (6) 6
miscellaneous compositions (6) 6
natural resins (6) 6
nitriles - therapeutic use (6) 6
paints (6) 6
pastes or solids for colouring or printing (6) 6
polishes (6) 6
randomized-trial (6) 6
triazoles - therapeutic use (6) 6
use of materials therefor (6) 6
woodstains (6) 6
breast neoplasms - diagnosis (5) 5
breast neoplasms - metabolism (5) 5
cancer (5) 5
compositions based thereon (5) 5
deoxycytidine - administration & dosage (5) 5
deoxycytidine - analogs & derivatives (5) 5
epirubicin (5) 5
macromolecular compounds obtained otherwise than by reactionsonly involving unsaturated carbon-to-carbon bonds (5) 5
medicine & public health (5) 5
neoplasm staging (5) 5
organic macromolecular compounds (5) 5
postmenopause (5) 5
premenopause (5) 5
survival analysis (5) 5
tamoxifen - administration & dosage (5) 5
their preparation or chemical working-up (5) 5
5-fluorouracil (4) 4
antineoplastic agents, hormonal - administration & dosage (4) 4
antineoplastic agents, hormonal - adverse effects (4) 4
aromatase inhibitors - adverse effects (4) 4
aromatase inhibitors - therapeutic use (4) 4
austria (4) 4
colorectal cancer (4) 4
cyclophosphamide (4) 4
cyclophosphamide - administration & dosage (4) 4
fluorouracil - administration & dosage (4) 4
gemcitabine (4) 4
letrozole (4) 4
leucovorin (4) 4
menopause (4) 4
neoplasm recurrence, local (4) 4
nitriles - adverse effects (4) 4
phase i-ii study (4) 4
receptors, estrogen - analysis (4) 4
tamoxifen - adverse effects (4) 4
triazoles - adverse effects (4) 4
adenocarcinoma - drug therapy (3) 3
austrian breast (3) 3
care and treatment (3) 3
cell lung-cancer (3) 3
clinical trials (3) 3
colorectal carcinoma (3) 3
deoxycytidine - adverse effects (3) 3
docetaxel (3) 3
epirubicin - administration & dosage (3) 3
fluorouracil (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 7, pp. 631 - 641
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2009, Volume 360, Issue 7, pp. 679 - 691
This large trial tested the effect of adding zoledronic acid to adjuvant endocrine treatment (goserelin plus tamoxifen or anastrozole) in premenopausal women... 
RECEIVING ADJUVANT LETROZOLE | MULTIPLE-MYELOMA | OVARIAN ABLATION | BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS | MEDICINE, GENERAL & INTERNAL | BONE LOSS | SOLID TUMORS | TAMOXIFEN | DELTA-T-CELLS | POSTMENOPAUSAL WOMEN | AUSTRIAN BREAST | Breast Neoplasms - surgery | Triazoles - adverse effects | Follow-Up Studies | Humans | Middle Aged | Receptors, Estrogen - analysis | Antineoplastic Agents, Hormonal - adverse effects | Aromatase Inhibitors - adverse effects | Antineoplastic Agents, Hormonal - therapeutic use | Diphosphonates - therapeutic use | Adult | Female | Chemotherapy, Adjuvant | Imidazoles - therapeutic use | Drug Therapy, Combination | Goserelin - therapeutic use | Aromatase Inhibitors - therapeutic use | Diphosphonates - adverse effects | Triazoles - therapeutic use | Bone Density Conservation Agents - adverse effects | Premenopause | Imidazoles - adverse effects | Bone Density Conservation Agents - therapeutic use | Breast Neoplasms - drug therapy | Disease-Free Survival | Estrogen Antagonists - therapeutic use | Tamoxifen - therapeutic use | Estrogen Antagonists - adverse effects | Tamoxifen - adverse effects | Nitriles - adverse effects | Nitriles - therapeutic use | Zoledronic acid | Care and treatment | Usage | Breast cancer | Health aspects | Function tests (Medicine) | Chemotherapy | Acids | Womens health | Menopause | Colorectal cancer | Cytotoxicity | Radiation therapy | Cancer therapies | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2012, Volume 30, Issue 7, pp. 722 - 728
Journal Article
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2007, Volume 68, Issue 2, pp. 334 - 340
Journal Article
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 12/2007, Volume 99, Issue 24, pp. 1845 - 1853
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 06/2002, Volume 8, Issue 6, pp. 1831 - 1837
Purpose: Hypoxia-inducible factor (HIF)-1α is a transcription factor that supports the adaptation of human cancer cells to hypoxia and is involved in various... 
CELLS | IMPACT | OVARIAN-TUMORS | FACTOR-1-ALPHA | ONCOLOGY | GROWTH | TUMOR ANGIOGENESIS | HIF-1-ALPHA | EXPRESSION | CHEMOTHERAPY | P53
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 03/2008, Volume 14, Issue 6, pp. 1767 - 1774
Journal Article
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 09/2009, Volume 15, Issue 18, pp. 5888 - 5894
Journal Article